Bishop Hans Edgar
Insider CIK 1480212 · A Director · JUNO See Remarks, Director · SANA Director · LYEL Director · CELG Director · AVNR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology, Inc. | A Award | 2026-10-05 | 2026-10-06 | 8,680 | — | $0 | 5,863,480 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2026-07-06 | 2026-07-07 | 6,297 | — | $0 | 5,854,800 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2026-04-06 | 2026-04-08 | 7,763 | — | $0 | 5,848,503 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2026-01-05 | 2026-01-06 | 6,157 | — | $0 | 5,840,740 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2025-10-06 | 2025-10-07 | 5,628 | — | $0 | 5,834,583 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2025-07-07 | 2025-07-08 | 7,842 | — | $0 | 5,828,955 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2025-04-07 | 2025-04-08 | 16,339 | — | $0 | 5,821,113 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2025-01-06 | 2025-01-07 | 14,285 | — | $0 | 5,804,774 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2024-10-07 | 2024-10-09 | 5,938 | — | $0 | 5,790,489 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2024-07-05 | 2024-07-08 | 4,911 | — | $0 | 5,784,551 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 130,000 | — | $0 | 130,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-07-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 54,278 | — | $0 | 54,278 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2024-04-05 | 2024-04-08 | 2,774 | — | $0 | 5,779,640 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2024-03-15 | 2024-03-19 | 750 | $147.48 | $110.6K | 24,976 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2024-03-15 | 2024-03-19 | 1,678 | $147.48 | $247.5K | 24,226 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2024-01-05 | 2024-01-08 | 4,901 | — | $0 | 5,776,866 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2023-10-05 | 2023-10-06 | 6,925 | — | $0 | 5,771,965 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2023-09-08 | 2023-09-08 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2023-07-05 | 2023-07-06 | 4,152 | — | $0 | 5,765,040 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2023-06-16 | 2023-06-20 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2023-04-05 | 2023-04-06 | 7,716 | — | $0 | 5,760,888 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2023-03-16 | 2023-03-20 | 741 | $136.82 | $101.4K | 22,379 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2023-03-16 | 2023-03-20 | 1,658 | $136.82 | $226.8K | 21,638 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2023-01-05 | 2023-01-06 | 6,702 | — | $0 | 5,753,172 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2022-10-05 | 2022-10-06 | 4,012 | — | $0 | 5,746,470 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | M Exercise deriv | 2022-09-08 | 2022-09-09 | 145,380 | — | $0 | 24,230 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | M Exercise | 2022-09-08 | 2022-09-09 | 145,380 | $0.10 | $14.5K | 4,685,614 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2022-07-05 | 2022-07-07 | 3,328 | — | $0 | 5,742,458 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2022-06-06 | 2022-06-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award | 2022-04-05 | 2022-04-06 | 2,880 | — | $0 | 5,739,130 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2022-03-17 | 2022-03-21 | 1,785 | $136.82 | $244.2K | 19,056 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2022-03-17 | 2022-03-21 | 797 | $136.82 | $109.0K | 19,853 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | M Exercise deriv | 2022-02-23 | 2022-02-25 | 993,428 | — | $0 | 169,610 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | M Exercise | 2022-02-23 | 2022-02-25 | 993,428 | $0.10 | $99.3K | 4,540,234 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 546,806 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 546,806 | — | $0 | 3,546,806 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2021-03-18 | 2021-03-22 | 822 | $121.59 | $99.9K | 17,176 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2021-03-18 | 2021-03-22 | 1,850 | $121.59 | $224.9K | 16,354 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 156,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 800,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 1,075,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 2,031,250 | — | $0 | 5,736,250 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2021-02-03 | 2021-02-18 | 23,591 | — | $0 | 23,591 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2020-08-03 | 2020-08-05 | 177 | $93.91 | $16.6K | 14,456 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2020-04-17 | 2020-04-21 | 1,027 | $73.01 | $75.0K | 14,228 | SEC↗ |
| A AGILENT TECHNOLOGIES, INC. | A Award | 2020-04-17 | 2020-04-21 | 3,081 | $73.01 | $224.9K | 13,201 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 13,266 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 1,454 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 4,756 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 23,088 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2019-06-03 | 2019-06-05 | 4,756 | — | $0 | 4,756 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2019-03-21 | 2019-03-22 | 2,823 | $82.00 | $231.5K | 9,405 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2019-03-21 | 2019-03-22 | 627 | $82.00 | $51.5K | 10,032 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 1,454 | — | $0 | 1,454 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 13,266 | — | $0 | 13,266 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2018-03-22 | 2018-03-23 | 1,438 | $67.47 | $97.0K | 6,522 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2018-03-22 | 2018-03-23 | 2,876 | $67.47 | $194.0K | 5,084 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 140,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 200,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 205,823 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer deriv | 2018-03-05 | 2018-03-07 | 451,756 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 33,133 | — | $0 | 102,319 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 35,893 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | U Tender | 2018-03-05 | 2018-03-07 | 2,263,948 | $87.00 | $196.96M | 184,281 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 66,426 | — | $0 | 35,893 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2018-03-05 | 2018-03-07 | 48,829 | $87.00 | $4.25M | 135,452 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | G Gift | 2018-02-07 | 2018-02-09 | 116,280 | — | $0 | 2,448,229 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | F Tax w/h | 2018-02-07 | 2018-02-09 | 4,346 | $85.49 | $371.5K | 2,564,509 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2018-01-31 | 2018-02-02 | 66,426 | — | $0 | 2,568,855 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2018-01-16 | 2018-01-18 | 245,750 | — | $0 | 451,756 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-16 | 2018-01-18 | 65,820 | $44.72 | $2.94M | 2,706,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2018-01-16 | 2018-01-18 | 245,750 | $6.36 | $1.56M | 2,772,679 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-16 | 2018-01-18 | 89,888 | $45.53 | $4.09M | 2,616,971 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-16 | 2018-01-18 | 49,082 | $46.52 | $2.28M | 2,567,889 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-16 | 2018-01-18 | 23,003 | $47.69 | $1.10M | 2,544,886 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2018-01-16 | 2018-01-18 | 42,457 | $48.56 | $2.06M | 2,502,429 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-10-20 | 2017-10-20 | 35,893 | — | $0 | 2,526,929 | SEC↗ |
| A AGILENT TECHNOLOGIES INC | A Award | 2017-07-18 | 2017-07-18 | 2,199 | $61.21 | $134.6K | 2,199 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2017-02-07 | 2017-02-09 | 205,823 | — | $0 | 205,823 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award | 2017-02-07 | 2017-02-09 | 44,177 | — | $0 | 2,491,036 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-09-27 | 2016-09-29 | 44,000 | — | $0 | 697,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-09-27 | 2016-09-29 | 44,000 | $6.36 | $279.8K | 2,490,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-09-27 | 2016-09-29 | 44,000 | $33.00 | $1.45M | 2,446,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-09-21 | 2016-09-21 | 6,057 | — | $0 | 741,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-09-21 | 2016-09-21 | 6,057 | $6.36 | $38.5K | 2,524,166 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-09-21 | 2016-09-21 | 77,307 | $30.30 | $2.34M | 2,446,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-09-20 | 2016-09-21 | 6,300 | — | $0 | 747,563 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-09-20 | 2016-09-21 | 6,300 | $30.00 | $189.0K | 2,518,109 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-09-20 | 2016-09-21 | 6,300 | $6.36 | $40.1K | 2,524,409 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-09-19 | 2016-09-21 | 428 | — | $0 | 753,863 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-09-19 | 2016-09-21 | 428 | $30.00 | $12.8K | 2,518,109 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-09-19 | 2016-09-21 | 428 | $6.36 | $2.7K | 2,518,537 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-09-08 | 2016-09-09 | 23,042 | — | $0 | 754,291 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-09-08 | 2016-09-09 | 23,042 | $30.06 | $692.6K | 2,518,109 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-09-08 | 2016-09-09 | 23,042 | $6.36 | $146.5K | 2,541,151 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-08-31 | 2016-09-02 | 18,173 | — | $0 | 777,333 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-08-31 | 2016-09-02 | 18,173 | $6.36 | $115.6K | 2,560,782 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-08-31 | 2016-09-02 | 42,673 | $30.06 | $1.28M | 2,518,109 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-06-30 | 2016-07-01 | 44,000 | — | $0 | 795,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-06-30 | 2016-09-02 | 44,000 | — | $0 | 795,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2016-06-30 | 2016-07-01 | 108,894 | $38.41 | $4.18M | 2,548,965 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-06-30 | 2016-07-01 | 44,000 | $6.36 | $279.8K | 2,657,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | D To issuer | 2016-06-30 | 2016-07-01 | 6,356 | $39.18 | $249.0K | 2,542,609 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-30 | 2016-09-02 | 108,894 | $38.41 | $4.18M | 2,548,965 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-06-30 | 2016-09-02 | 44,000 | $6.36 | $279.8K | 2,657,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-30 | 2016-09-02 | 6,356 | $39.18 | $249.0K | 2,542,609 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-06-09 | 2016-06-13 | 54,000 | — | $0 | 839,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-09 | 2016-06-13 | 59,675 | $45.80 | $2.73M | 2,644,934 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-06-09 | 2016-06-13 | 54,000 | $6.36 | $343.4K | 2,704,609 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-09 | 2016-06-13 | 16,751 | $47.03 | $787.8K | 2,628,183 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-09 | 2016-06-13 | 8,394 | $47.97 | $402.7K | 2,619,789 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-06-09 | 2016-06-13 | 5,930 | $48.74 | $289.0K | 2,613,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2016-02-29 | 2016-03-02 | 54,000 | — | $0 | 893,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2016-02-29 | 2016-03-02 | 54,000 | $6.36 | $343.4K | 2,741,359 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-02-29 | 2016-03-02 | 3,879 | $36.46 | $141.4K | 2,650,609 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-02-29 | 2016-03-02 | 86,871 | $35.27 | $3.06M | 2,654,488 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2016-02-02 | 2016-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise deriv | 2015-12-15 | 2015-12-17 | 54,000 | — | $0 | 947,506 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-12-15 | 2015-12-17 | 30,841 | $44.77 | $1.38M | 2,748,018 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-12-15 | 2015-12-17 | 31,255 | $46.64 | $1.46M | 2,687,359 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2015-12-15 | 2015-12-17 | 29,404 | $45.73 | $1.34M | 2,718,614 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | M Exercise | 2015-12-15 | 2015-12-17 | 54,000 | $6.36 | $343.4K | 2,778,859 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2015-03-03 | 2015-03-05 | 140,000 | — | $0 | 140,000 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-02-12 | 2014-02-14 | 28,900 | — | $0 | 93,350 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2013-02-14 | 2013-02-19 | 19,450 | — | $0 | 64,450 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-05-23 | 2012-05-25 | 45,000 | — | $0 | 45,000 | SEC↗ |